Cargando…
Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017
BACKGROUND: We aimed to evaluate the impact of national health programs implemented in Kazakhstan from 2011 on CVD incidence and mortality. METHODS: Incidence and mortality rates from CVD were studied in Kazakhstan from 2004 to 2017. The official data obtained from “Medinform” company were analyzed...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288408/ https://www.ncbi.nlm.nih.gov/pubmed/35936532 http://dx.doi.org/10.18502/ijph.v51i4.9243 |
_version_ | 1784748467820691456 |
---|---|
author | Mukasheva, Gulbarshyn Abenova, Madina Shaltynov, Askhat Tsigengage, Oxana Mussabekova, Zhanna Bulegenov, Tolkyn Shalgumbaeva, Gulnara Semenova, Yuliya |
author_facet | Mukasheva, Gulbarshyn Abenova, Madina Shaltynov, Askhat Tsigengage, Oxana Mussabekova, Zhanna Bulegenov, Tolkyn Shalgumbaeva, Gulnara Semenova, Yuliya |
author_sort | Mukasheva, Gulbarshyn |
collection | PubMed |
description | BACKGROUND: We aimed to evaluate the impact of national health programs implemented in Kazakhstan from 2011 on CVD incidence and mortality. METHODS: Incidence and mortality rates from CVD were studied in Kazakhstan from 2004 to 2017. The official data obtained from “Medinform” company were analyzed based on the annual population statistics. RESULTS: There was an increase in the incidence of cardiovascular disease among the population of Kazakhstan from 1845.4 per 100,000 in 2004 to 2597.5 per 100,000 in 2017. This might be attributed to the implementation of the national health programs, which improved early CVD identification. Incidence of ischemic heart disease (IHD) was grown almost in all provinces of Kazakhstan during the study period. The mortality from cardiovascular disease had a considerable decline over the study period, in particular after 2010, it might be influenced by early diagnosis and provision of timely treatment. CONCLUSION: The experience of Kazakhstan national health programs shows improved identification of CVD and IHD and timely treatment for cardiovascular disease. A significant variation in incidence and mortality rates of cardiovascular disease was observed between the country provinces. |
format | Online Article Text |
id | pubmed-9288408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-92884082022-08-04 Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017 Mukasheva, Gulbarshyn Abenova, Madina Shaltynov, Askhat Tsigengage, Oxana Mussabekova, Zhanna Bulegenov, Tolkyn Shalgumbaeva, Gulnara Semenova, Yuliya Iran J Public Health Original Article BACKGROUND: We aimed to evaluate the impact of national health programs implemented in Kazakhstan from 2011 on CVD incidence and mortality. METHODS: Incidence and mortality rates from CVD were studied in Kazakhstan from 2004 to 2017. The official data obtained from “Medinform” company were analyzed based on the annual population statistics. RESULTS: There was an increase in the incidence of cardiovascular disease among the population of Kazakhstan from 1845.4 per 100,000 in 2004 to 2597.5 per 100,000 in 2017. This might be attributed to the implementation of the national health programs, which improved early CVD identification. Incidence of ischemic heart disease (IHD) was grown almost in all provinces of Kazakhstan during the study period. The mortality from cardiovascular disease had a considerable decline over the study period, in particular after 2010, it might be influenced by early diagnosis and provision of timely treatment. CONCLUSION: The experience of Kazakhstan national health programs shows improved identification of CVD and IHD and timely treatment for cardiovascular disease. A significant variation in incidence and mortality rates of cardiovascular disease was observed between the country provinces. Tehran University of Medical Sciences 2022-04 /pmc/articles/PMC9288408/ /pubmed/35936532 http://dx.doi.org/10.18502/ijph.v51i4.9243 Text en Copyright © 2022 Mukasheva et al. Published by Tehran University of Medical Sciences https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. |
spellingShingle | Original Article Mukasheva, Gulbarshyn Abenova, Madina Shaltynov, Askhat Tsigengage, Oxana Mussabekova, Zhanna Bulegenov, Tolkyn Shalgumbaeva, Gulnara Semenova, Yuliya Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017 |
title | Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017 |
title_full | Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017 |
title_fullStr | Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017 |
title_full_unstemmed | Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017 |
title_short | Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017 |
title_sort | incidence and mortality of cardiovascular disease in the republic of kazakhstan: 2004–2017 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288408/ https://www.ncbi.nlm.nih.gov/pubmed/35936532 http://dx.doi.org/10.18502/ijph.v51i4.9243 |
work_keys_str_mv | AT mukashevagulbarshyn incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017 AT abenovamadina incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017 AT shaltynovaskhat incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017 AT tsigengageoxana incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017 AT mussabekovazhanna incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017 AT bulegenovtolkyn incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017 AT shalgumbaevagulnara incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017 AT semenovayuliya incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017 |